KBC Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
KBC Group's CNMD Position: Q1 2026 in Review
KBC Group held its CONMED (CNMD) position steady in Q1 2026 at 899 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.
KBC Group first reported a position in CNMD in Q2 2019 and has held it in 28 quarters since. The position peaked at $5.1M in Q4 2020. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- KBC Group held 899 shares of CONMED worth $32K as of Q1 2026.
- KBC Group left its CONMED share count unchanged in Q1 2026.
- CONMED made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1780 holding.
- KBC Group first reported a position in CONMED in Q2 2019 and has held it in 28 quarters since.
- KBC Group's CONMED position peaked at $5.1M in Q4 2020.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.